<SEC-DOCUMENT>0001193125-25-091650.txt : 20250424
<SEC-HEADER>0001193125-25-091650.hdr.sgml : 20250424
<ACCEPTANCE-DATETIME>20250423183729
ACCESSION NUMBER:		0001193125-25-091650
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20250424
DATE AS OF CHANGE:		20250423
EFFECTIVENESS DATE:		20250424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Churchill Downs Inc
		CENTRAL INDEX KEY:			0000020212
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-RACING, INCLUDING TRACK OPERATION [7948]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				610156015
		STATE OF INCORPORATION:			KY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286714
		FILM NUMBER:		25863005

	BUSINESS ADDRESS:	
		STREET 1:		600 N HURSTBOURNE PKWY
		STREET 2:		STE 400
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40222-5389
		BUSINESS PHONE:		15023941166

	MAIL ADDRESS:	
		STREET 1:		600 N HURSTBOURNE PKWY
		STREET 2:		STE 400
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40222-5389

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHURCHILL DOWNS Inc
		DATE OF NAME CHANGE:	20160105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHURCHILL DOWNS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d902037ds8.htm
<DESCRIPTION>S-8
<TEXT>
<HTML><HEAD>
<TITLE>S-8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on April&nbsp;23, 2025 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-&#8195;&#8195;&#8195;</FONT></B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-8</FONT></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CHURCHILL DOWNS INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Kentucky</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">61-0156015</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Incorporation or Organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>600 North Hurstbourne Parkway, Suite 400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Louisville, Kentucky 40222 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address and Zip Code of Principal Executive Offices) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Churchill Downs Incorporated 2025 Omnibus Stock and Incentive Plan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Full title of the plans) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Bradley K. Blackwell </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Executive Vice President and General Counsel&#8194; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>600 North Hurstbourne Parkway, Suite 400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Louisville, Kentucky 40222 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (502) <FONT STYLE="white-space:nowrap">636-4400</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, Address, and Telephone Number, including Area Code, of Agent for Service) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company. See definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging growth company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&#8194;&#9744; </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All information required by Part I to be contained in the prospectus is omitted from this Registration Statement in accordance with the
explanatory note to Part I of Form <FONT STYLE="white-space:nowrap">S-8</FONT> and Rule 428 under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). This Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-8</FONT> is filed by Churchill Downs Incorporated (the &#147;Registrant&#148;) regarding the Churchill Downs Incorporated 2025 Omnibus Stock and Incentive Plan (the &#147;Plan&#148;). Documents containing the
information required by Part I of the Registration Statement will be sent or given to participants in the Plan as specified by Rule 428(b)(1) under the Securities Act. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION
REQUIRED IN THE REGISTRATION STATEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;3. Incorporation of Documents by Reference. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following documents filed with the Securities and Exchange Commission (the &#147;Commission&#148;) by the Registrant are hereby
incorporated in this Registration Statement by reference (other than information in such filings deemed, under Commission rules or otherwise, not to have been filed with the Commission): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant&#146;s Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000020212/000002021225000051/chdn-20241231.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for its fiscal year ended December&nbsp;31, 2024, filed with the Commission on February&nbsp;20, 2025; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant&#146;s Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/20212/000002021225000067/chdn-20250331.htm">Form
 <FONT STYLE="white-space:nowrap">10-Q</FONT></A> for the quarter ended March&nbsp;31, 2025, filed with the Commission on April&nbsp;23, 2025; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Registrant&#146;s Current Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the
Commission on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000020212/000119312525027242/d916166d8k.htm">February<U></U>&nbsp;
14, 2025</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/0000020212/000002021225000056/chdn-20250311.htm">March<U></U>&nbsp;
14, 2025</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/20212/000002021225000062/chdn-20250422.htm">April&nbsp;22, 2025</A>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The description of the Registrant&#146;s Common Stock, no par value, which is contained in the
Registrant&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the Commission on December&nbsp;14, 1998 and the Registrant&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the
Commission on July&nbsp;29, 2005, and any amendment or report filed for the purpose of updating such description, including <A HREF="http://www.sec.gov/Archives/edgar/data/20212/000002021221000019/exhibit4fdescriptionofsecu.htm">Exhibit 4.10</A> to
the Registrant&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2023. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, all documents filed by the Registrant pursuant to Section&nbsp;13(a), 13(c), 14, and 15(d) of the Securities Exchange Act of
1934, as amended (the &#147;Exchange Act&#148;), subsequent to the date of this Registration Statement (other than information in such filings deemed, under Commission rules or otherwise, not to have been filed with the Commission) and prior to the
filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this
Registration Statement and to be a part hereof from the date of filing of such documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any statement contained in this Registration
Statement or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained or incorporated by reference
herein or in any subsequently filed document that is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to
constitute a part of this Registration Statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;4. Description of Securities. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;5. Interests of Named Experts and Counsel. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;6.
Indemnification of Directors and Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Article XI of the Registrant&#146;s Amended and Restated Articles of Incorporation, as
amended, limits the liability of directors of the Registrant pursuant to the Kentucky Business Corporation Act. Under this article, directors generally are personally liable to the Registrant or its shareholders for monetary damages only for
transactions involving conflicts of interest or improper personal benefits received by a director, intentional misconduct, known violations of law, or approving unlawful distributions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Bylaws of the Registrant require the Registrant to indemnify and hold harmless each director and officer and permit
the Registrant to indemnify and hold harmless any other employee or agent of the Registrant who is, was or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative and whether formal or informal by reason of the fact that he or she is or was a director, officer, employee or agent of the Registrant, or while a director, officer, employee or agent of the Registrant, is or was serving the
Registrant or any other legal entity in any capacity (including, without limitation, as a director, officer, partner, manager, trustee, employee or agent of another foreign or domestic corporation, partnership, joint venture, trust, limited
liability company, employee benefit plan or other enterprise) at the request of the Registrant, against all liability and loss suffered and expenses (including any obligation to pay a judgment, settlement, penalty or fine) incurred by such person to
the fullest extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Bylaws of the Registrant further provide that the Registrant shall pay
expenses (including attorneys&#146; fees) incurred by an officer or director in defending any proceeding in advance of its final disposition, provided, however, that the payment of such expenses shall be made only upon receipt of an undertaking by
the person to repay all amounts advanced if it shall ultimately be determined that the person is not entitled to be indemnified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
circumstances under which Kentucky law requires or permits a corporation to indemnify its directors, officers, employees and/or agents are set forth at KRS <FONT STYLE="white-space:nowrap">271B.8-500,</FONT> et seq. Generally, under KRS <FONT
STYLE="white-space:nowrap">271B.8-500</FONT> et seq., a corporation may indemnify an individual made a party to a proceeding because he is or was a director against liability incurred in the proceeding if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he conducted himself in good faith; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">he honestly believed </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of conduct in his official capacity with the corporation, that his conduct was in its best
interests; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in all other cases, that his conduct was at least not opposed to its best interests. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the case of any criminal proceeding, he had no reasonable cause to believe his conduct was unlawful.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A corporation may not indemnify a director: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in connection with a proceeding by or in the right of the corporation in which the director was adjudged liable
to the corporation; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in connection with any other proceeding charging improper personal benefit to him, whether or not involving
action in his official capacity, in which he was adjudged liable on the basis that personal benefit was improperly received by him. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indemnification permitted in connection with a proceeding by or in the right of the corporation is limited to reasonable expenses incurred in
connection with the proceeding. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Registrant maintains directors&#146; and officers&#146; liability insurance
covering certain liabilities which may be incurred by the directors and officers of the Registrant in connection with the performance of their duties. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;7. Exemption from Registration Claimed. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;8. Exhibits.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exhibit<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/20212/000002021223000078/ex324-25x23.htm">Amended and Restated Articles of Incorporation of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant&#146;s Current Report
 on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the Commission on April&nbsp;25, 2023). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/20212/000002021223000078/ex314-25x23.htm">Articles of Amendment to the Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrant&#146;s Current
Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the Commission on April&nbsp;25, 2023). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/20212/000002021222000144/ex31.htm">Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> filed with the Commission on October&nbsp;25, 2022). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;4.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d902037dex41.htm">Churchill Downs Incorporated 2025 Omnibus Stock and Incentive Plan. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;&#8199;5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d902037dex51.htm">Opinion of Kaplan Johnson Abate&nbsp;&amp; Bird LLP with respect to validity of issuance of securities. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d902037dex231.htm">Consent of Independent Registered Public Accounting Firm. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d902037dex51.htm">Consent of Kaplan Johnson Abate&nbsp;&amp; Bird LLP (included in the opinion filed as Exhibit 5.1).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (included on the signature pages to the Registration Statement and incorporated herein by reference).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>107*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d902037dexfilingfees.htm">Filing Fee Table. </A></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Filed herewith. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;9. Undertakings. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) The undersigned
Registrant hereby undertakes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To file, during any period in which offers or sales are being made, a post-effective amendment to this
Registration Statement: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or
any material change to such information in this Registration Statement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not
apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or Section&nbsp;15(d) of the
Exchange Act that are incorporated by reference in this Registration Statement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Registrant&#146;s annual report pursuant to Section&nbsp;13(a) or Section&nbsp;15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to
Section&nbsp;15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide</I> offering thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is
against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the
final adjudication of such issue. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on Form <FONT STYLE="white-space:nowrap">S-8</FONT> and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Louisville, Kentucky,
on April 23, 2025. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CHURCHILL DOWNS INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ William C. Carstanjen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">William C. Carstanjen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, the undersigned officers and directors of Churchill Downs Incorporated, hereby severally constitute and appoint William C. Carstanjen, Marcia A. Dall and
Bradley K. Blackwell, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names in the capacities indicated below, the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT>
filed herewith and any and all subsequent amendments to said Registration Statement, and generally to do all such things in our names and on our behalf in our capacities as officers and directors to enable Churchill Downs Incorporated to comply with
the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorneys, or any of them, to said
Registration Statement and any and all amendments thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration
Statement has been signed by the following persons in the capacities and on the dates indicated. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>Signature</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Title</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Date</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ William C. Carstanjen</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">William C. Carstanjen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director, Chief Executive Officer<BR><I>(Principal Executive Officer)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Marcia A. Dall</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Marcia A. Dall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Executive Vice President and Chief Financial Officer<BR><I>(Principal Financial Officer and Principal Accounting Officer)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ R. Alex Rankin</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R. Alex Rankin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Andr&eacute;a Carter</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Andr&eacute;a Carter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Paul C. Varga</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Paul C. Varga</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Douglas C. Grissom</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Douglas C. Grissom</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Daniel P. Harrington</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Daniel P. Harrington</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Karole F. Lloyd</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Karole F. Lloyd</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">April&nbsp;23, 2025</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d902037dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHURCHILL DOWNS INCORPORATED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2025 OMNIBUS STOCK AND INCENTIVE PLAN </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHURCHILL DOWNS INCORPORATED </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2025 OMNIBUS STOCK AND INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <I>Purpose.</I> The purpose of the Churchill Downs Incorporated 2025 Omnibus Stock and Incentive Plan (the &#147;<I>Plan</I>&#148;) is to
attract and retain employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for Churchill Downs Incorporated and its Subsidiaries and to provide such persons with incentives and rewards for superior performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <I>Definitions. </I>As used in this Plan, the following terms shall be defined as set forth below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1. &#147;<I>Award</I>&#148; means any Option, Stock Appreciation Right, Restricted Shares, Restricted Share Units, Performance Shares,
Performance Units, Other Share-Based Award, or Performance Cash granted under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2. &#147;<I>Award</I><I> Agreement&#148;</I>
means an agreement, certificate, resolution or other form of writing or other evidence approved by the Committee which sets forth the terms and conditions of an Award. An Award Agreement may be in an electronic medium, may be limited to a notation
on the Company&#146;s books and records and, if approved by the Committee, need not be signed by a representative of the Company or a Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3. &#147;<I>Base</I><I> Price&#148;</I> means the price to be used as the basis for determining the Spread upon the exercise of a
Freestanding Stock Appreciation Right. Except in the case of a Substitute Award, in no case shall the Base Price be less than the Fair Market Value on the Grant Date of the Freestanding Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4. &#147;<I>Board</I>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5. &#147;<I>Change</I><I> in Control&#148;</I> means the first to occur of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the acquisition, directly or indirectly, by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or 14(d)(2) of the
Exchange Act) (a &#147;<I>Person</I>&#148;) of beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of more than 50% of either the then outstanding voting securities of
the Company (the &#147;<I>Outstanding</I><I> Company Common Stock&#148;)</I> or the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the
&#147;<I>Outstanding</I><I> Company Voting Securities&#148;);</I> provided, however that for purposes of this subsection (a), the following acquisitions shall not constitute a Change in Control: (w)&nbsp;any acquisition directly from the Company,
(x)&nbsp;any acquisition by the Company or any of its subsidiaries, (y)&nbsp;any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or (z)&nbsp;any
acquisition by any corporation pursuant to a transaction which complies with clauses (A), (B) and (C)&nbsp;of subsection (c)&nbsp;of this definition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;during any twenty-four (24)&nbsp;month period, individuals who, as of the beginning of each period, constitute the Board (the
&#147;<I>Incumbent</I><I> Board&#148;)</I> cease for any reason to </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the
Company&#146;s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any
such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf
of a Person other than the Board; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;consummation of a reorganization, merger or consolidation or sale or other disposition of all
or substantially all of the assets of the Company or the acquisition of assets of another entity (a &#147;<I>Corporate</I><I> Transaction&#148;),</I> in each case, unless, immediately following such Corporate Transaction, (A)&nbsp;all or
substantially all of the individuals and entities who were the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Corporate Transaction beneficially own,
directly or indirectly, more than 50% of, respectively, the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be,
of the corporation resulting from such Corporate Transaction (including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially all of the Company&#146;s assets either directly or through one or
more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction, of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be, (B)&nbsp;no Person
(excluding any corporation resulting from such Corporate Transaction or employee benefit plan (or related trust) of the Company or such corporation resulting from such Corporate Transaction) beneficially owns, directly or indirectly, 50% or more of,
respectively, the then-Outstanding Company Common Stock resulting from such Corporate Transaction or the Outstanding Company Voting Securities resulting from such Corporate Transaction, except to the extent that such ownership existed prior to the
Corporate Transaction, and (C)&nbsp;at least a majority of the members of the Board resulting from the Corporate Transaction were members of the Incumbent Board at the time of the execution of the initial plan or action of the Board providing for
such Corporate Transaction; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;approval by the shareholders of the Company of a complete liquidation or dissolution of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Solely with respect to any award that constitutes &#147;deferred compensation&#148; subject to Section&nbsp;409A of the Code and that is payable
on account of a Change in Control (including any installments or stream of payments that are accelerated on account of a Change in Control), a Change in Control shall occur only if such event also constitutes a &#147;change in the ownership&#148;,
&#147;change in effective control&#148;, and/or a &#147;change in the ownership of a substantial portion of assets&#148; of the Company as those terms are defined under Treasury Regulation
<FONT STYLE="white-space:nowrap">&#167;1.409A-3(i)(5),</FONT> but only to the extent necessary to establish a time or form of payment that complies with Section&nbsp;409A of the Code, without altering the definition of Change in Control for purposes
of determining whether a participant&#146;s rights to such Award become vested or otherwise unconditional upon the Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6. &#147;<I>Code</I>&#148; means the Internal Revenue Code of 1986, as amended from time
to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7. &#147;<I>Committee</I>&#148; means the Compensation Committee of the Board, or a subcommittee thereof, or such other
committee designated by the Board, in each case, consisting of two or more members of the Board, each of whom is intended to be (i)&nbsp;a <FONT STYLE="white-space:nowrap">&#147;Non-Employee</FONT> Director&#148; within the meaning of Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act and (ii) &#147;independent&#148; within the meaning of the rules of the Nasdaq Global Select Market or, if the Shares are not listed on the Nasdaq Global Select Market, within the
meaning of the rules of the principal securities exchange on which the Shares are then traded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8. &#147;<I>Company</I>&#148; means
Churchill Downs Incorporated, a Kentucky corporation, or any successor corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9. &#147;<I>Deferral</I><I> Period&#148;</I> means
the period of time during which Restricted Share Units are subject to deferral limitations under Section&nbsp;9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10.
&#147;<I>Employee</I>&#148; means any person, including an officer, employed by the Company or a Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11.
&#147;<I>Exchange</I><I> Act&#148;</I> means the Securities Exchange Act of 1934, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12. &#147;<I>Fair</I><I> Market
Value&#148;</I> means the closing price for the Shares on the date as of which such value is being determined, as reported on the Nasdaq Global Select Market or the principal securities exchange on which the Shares are listed for trading or, if
there were no sales on such date, the closing price on the nearest preceding date on which sales occurred, in each case, as reported in <I>The Wall Street Journal</I> or such other source as the Committee deems reliable; provided, however, that the
Company may in its discretion use the closing transaction price of a Share on the day preceding the date as of which such value is being determined to the extent the Company determines such method is more practical for administrative purposes, such
as for purposes of tax withholding. If the Shares are not listed on a national securities exchange or if Fair Market Value for any date cannot be so determined, Fair Market Value shall be determined by the Committee by whatever means or method as
the Committee, in the good faith exercise of its discretion, shall at such time deem appropriate and in compliance with Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13. &#147;<I>Freestanding</I><I> Stock Appreciation Right&#148;</I> means a Stock Appreciation Right granted pursuant to Section&nbsp;7 that
is not granted in tandem with an Option or similar right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.14. &#147;<I>Grant</I><I> Date&#148;</I> means the date specified by the
Committee on which a grant of an Award shall become effective, which shall not be earlier than the date on which the Committee takes action with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.15. &#147;<I>Incentive</I><I> Stock Option&#148;</I> means any Option that meets the requirements of Code Section&nbsp;422 or any successor
provision, which is intended by the Committee to constitute an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.16. &#147;<I>Nonemployee</I><I>
Director&#148;</I> means a member of the Board who is not an Employee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.17. &#147;<I>Nonqualified</I><I> Stock Option&#148;</I> means an Option that is not an
Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.18. &#147;<I>Option</I>&#148; means any option to purchase Shares granted under Section&nbsp;6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.19. &#147;<I>Optionee</I>&#148; means the person so designated in an Award Agreement evidencing an outstanding Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.20. &#147;<I>Option</I><I> Price&#148;</I> means the purchase price payable upon the exercise of an Option. Except in the case of a
Substitute Award, in no case shall the Option Price be less than the Fair Market Value on the Grant Date of the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.21.
&#147;<I>Other</I><I> Share-Based Award&#148;</I> shall mean an award granted pursuant to Section&nbsp;11. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.22.
&#147;<I>Participant</I>&#148; means an Employee or Nonemployee Director who is selected by the Committee to receive benefits under this Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.23. <I>&#147;Performance Award&#148;</I> shall mean any Award of Performance Cash, Performance Shares or Performance Units awarded pursuant
to Section&nbsp;10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.24. <I>&#147;Performance Cash&#148;</I> shall mean any cash incentives awarded pursuant to Section&nbsp;10. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.25. &#147;<I>Performance</I><I> Objectives&#148;</I> means the performance objectives established pursuant to this Plan for Participants who
have received Awards. Performance Objectives may be described in terms of Company-wide objectives or objectives that are related to the performance of the individual Participant or the Subsidiary, division, department or function within the Company
or Subsidiary in which the Participant is employed. Performance Objectives may be measured on an absolute or relative basis. Relative performance may be measured by a group of peer companies or by a financial market index. Performance Objectives may
be based on specified levels of or increases in the Company&#146;s or Subsidiary&#146;s return on equity, earnings before or after deduction for all or any portion of interest, taxes, depreciation, or amortization, whether or not on a continuing
operations or an aggregate or per share basis, net earnings per share, diluted earnings per share, total earnings, earnings growth, return on capital, cost of capital, return on assets, return on investment, return on equity, net customer sales,
volume, sales growth, gross profit, gross margin return on investment, share price (including but not limited to, growth measures and total stockholder return), operating profit, operating margin, net operating profit after taxes, net earnings, cash
flow (including, but not limited to, operating cash flow and free cash flow), cash flow return on investment (which equals net cash flow divided by total capital), financial return ratios, total return to shareholders, market share, earnings
measures/ratios, economic value added (EVA), balance sheet measurements, asset growth, market share, internal rate of return, increase in net present value or expense targets, &#147;Employer of Choice&#148; or similar survey results, customer
satisfaction surveys and productivity, <FONT STYLE="white-space:nowrap">ESG-related</FONT> metrics, or any other performance objectives selected by the Committee whether or not listed herein. Any Performance Objectives that are financial metrics,
may be determined in accordance with United States Generally Accepted Accounting Principles or may be adjusted when established to include or exclude any items otherwise includable or excludable under GAAP. Potential adjustments include, but are not
limited to: (a)&nbsp;restructurings, discontinued operations, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">extraordinary items, and other unusual, infrequently occurring or
<FONT STYLE="white-space:nowrap">non-recurring</FONT> charges or events; (b)&nbsp;asset write-downs; (c)&nbsp;significant litigation or claim judgments or settlements; (d)&nbsp;acquisitions or divestitures; (e)&nbsp;any reorganization or change in
the corporate structure or capital structure of the Company; (f)&nbsp;an event either not directly related to the operations of the Company, Subsidiary, division, business segment or business unit or not within the reasonable control of management;
(g)&nbsp;foreign exchange gains and losses; (h)&nbsp;a change in the fiscal year of the Company; (i)&nbsp;the cumulative effects of tax or accounting changes in accordance with U.S. generally accepted accounting principles; or (j)&nbsp;the effect of
changes in other laws or regulatory rules affecting reporting results. If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business,
or other events or circumstances render the Performance Objectives unsuitable, the Committee may modify such Performance Objectives or the related minimum acceptable level of achievement, in whole or in part, as the Committee deems appropriate and
equitable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.26. &#147;<I>Performance</I><I> Period&#148;</I> means a period of time established by the Committee within which the
Performance Objectives relating to an Award are to be achieved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.27. &#147;<I>Performance</I><I> Share&#148;</I> means a bookkeeping
entry that records the equivalent of one Share awarded pursuant to Section&nbsp;10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.28. &#147;<I>Performance</I><I> Unit&#148;</I>
means a bookkeeping entry that records a unit equivalent to $1.00 awarded pursuant to Section&nbsp;10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.29. &#147;<I>Prior</I><I>
Plan&#148; </I>means the Company&#146;s 2016 Omnibus Stock Incentive Plan and 2007 Omnibus Stock Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.30.
<I>&#147;Restricted Share Units&#148; </I>means an Award pursuant to Section&nbsp;8 of the right to receive Shares or, in lieu thereof and to the extent provided in the applicable Award Agreement, the Fair Market Value of such Shares in cash at the
end of a specified Deferral Period (including, the right to receive fully vested but deferred Share units). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.31.
&#147;<I>Restricted</I><I> Shares&#148;</I> mean Shares granted under Section&nbsp;8 subject to a substantial risk of forfeiture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.32.
&#147;<I>Shares</I>&#148; means shares of the Common Stock of the Company, no par value, or any security into which Shares may be converted by reason of any transaction or event of the type referred to in Section&nbsp;13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.33. &#147;<I>Spread</I>&#148; means, in the case of a Freestanding Stock Appreciation Right, the amount by which the Fair Market Value on
the date when any such right is exercised exceeds the Base Price specified in such right or, in the case of a Tandem Stock Appreciation Right, the amount by which the Fair Market Value on the date when any such right is exercised exceeds the Option
Price specified in the related Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.34. &#147;<I>Stock</I><I> Appreciation Right&#148;</I> means a right granted under
Section&nbsp;7, including a Freestanding Stock Appreciation Right or a Tandem Stock Appreciation Right. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.35. &#147;<I>Subsidiary</I>&#148; means a corporation or other entity in which the Company
has a direct or indirect ownership or other equity interest, provided that for purposes of determining whether any person may be a Participant for purposes of any grant of Incentive Stock Options, &#147;Subsidiary&#148; means any corporation (within
the meaning of the Code) in which the Company owns or controls directly or indirectly more than 50&nbsp;percent of the total combined voting power represented by all classes of stock issued by such corporation at the time of such grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.36. <I>&#147;Substitute Awards&#148;</I> shall mean Awards granted or Shares issued by the Company under this Plan upon the assumption of,
or in substitution for, outstanding equity awards previously granted by a company or other entity in connection with a corporate transaction, including a merger, combination, consolidation or acquisition of property or stock; provided, however, that
in no event shall the term &#147;Substitute Award&#148; be construed to refer to an award made in connection with the cancellation and repricing of an Option or Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.37. &#147;<I>Tandem</I><I> Stock Appreciation Right&#148;</I> means a Stock Appreciation Right granted pursuant to Section&nbsp;7 that is
granted in tandem with an Option or any similar right granted under any other plan of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Shares Available Under the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1. <I>Reserved Shares Available for Awards. </I>Subject to adjustment as provided in Section&nbsp;13, the maximum number of Shares that
shall initially be available for all Awards under this Plan, other than Substitute Awards, shall be 3,300,000 Shares, less one (1)&nbsp;Share for every one (1)&nbsp;Share granted under the Prior Plan after December&nbsp;31, 2024. After the Effective
Date of the Plan, no awards may be granted under the Prior Plan. The number of Shares that remain available for future grants under the Plan shall be reduced by the sum of the aggregate number of Shares which become subject to outstanding Awards
denominated in Shares, other than Substitute Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2. <I>Permitted Addbacks. </I>If (i)&nbsp;any Shares subject to an Award are
forfeited, an Award expires or an Award is settled for cash (in whole or in part), or (ii)&nbsp;after December&nbsp;31, 2024 any Shares subject to an award under the Prior Plan are forfeited, an award under the Prior Plan expires or is settled for
cash (in whole or in part), then in each such case the Shares subject to such Award or award under the Prior Plan shall, to the extent of such forfeiture, expiration or cash settlement, be added to the Shares available for Awards under the Plan. In
the event that withholding tax liabilities arising from an Award other than an Option or Stock Appreciation Right or, after December&nbsp;31, 2024, an award other than an option or stock appreciation right under the Prior Plan are satisfied by the
tendering of Shares (either actually or by attestation) or by the withholding of Shares by the Company, the Shares so tendered or withheld shall be added to the Shares available for Awards under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3. <I>No Recycling of Options or SARs. </I>Notwithstanding anything to the contrary contained herein, the following Shares shall not be
added to the Shares authorized for grant under Section&nbsp;3.1: (i) Shares tendered by the Participant or withheld by the Company in payment of the purchase price of an Option or, after December&nbsp;31, 2024,<B> </B>an option under the Prior Plan;
(ii)&nbsp;Shares tendered by the Participant or withheld by the Company to satisfy any tax withholding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligation with respect to Options or Stock Appreciation Rights or, after December&nbsp;31, 2024,<B> </B>options or stock appreciation rights under the Prior Plan; (iii)&nbsp;Shares subject to a
Stock Appreciation Right or, after December&nbsp;31, 2024,<B> </B>a stock appreciation right under the Prior Plan that are not issued in connection with its stock settlement on exercise thereof; and (iv)&nbsp;Shares reacquired by the Company on the
open market or otherwise using cash proceeds from the exercise of Options or, after December&nbsp;31, 2024,<B> </B>options under the Prior Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4. <I>ISO Maximum.</I> In no event shall the number of Shares issued upon the exercise of Incentive Stock Options exceed 3,300,000 Shares,
subject to adjustment as provided in Section&nbsp;13. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5. <I>Limitations on Awards to Nonemployee Directors.</I> Notwithstanding any
provision contained herein to the contrary, the maximum number of Shares subject to Awards granted during a single calendar year to any Nonemployee Director, taken together with any cash fees paid to such Nonemployee Director during the calendar
year, shall not exceed $750,000 in total value (calculating the value of any such Awards based on the grant date fair value of such Awards for financial reporting purposes); provided that the limitations set forth in this Section&nbsp;3.5 shall not
apply to distributions of previously deferred compensation under a deferred compensation plan maintained by the Company or any Subsidiary or with respect to any compensation received by the director in his or her capacity as an executive officer or
employee of the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6. <I>Substitute Awards.</I> Substitute Awards shall not reduce the Shares authorized for
grant under the Plan or the applicable limitations for grant to a Nonemployee Director under Section&nbsp;3.5, nor shall Shares subject to a Substitute Award again be available for Awards under the Plan as provided in this Section&nbsp;3.
Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available under a <FONT STYLE="white-space:nowrap">pre-existing</FONT> plan approved by stockholders
and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such <FONT STYLE="white-space:nowrap">pre-existing</FONT> plan (as adjusted, to the extent appropriate, using the exchange
ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards
under the Plan and shall not reduce the Shares authorized for grant under the Plan; provided that Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the <FONT
STYLE="white-space:nowrap">pre-existing</FONT> plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees or Nonemployee Directors prior to such acquisition or combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7. <I>Awards Settled in Cash.</I> Awards (including awards outstanding under a Prior Plan) valued by reference to Shares that are settled in
equivalent cash or property value will not count against the limitations in this Section&nbsp;3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8. <I>Character of Shares.</I> Any
Shares issued hereunder may consist, in whole or in part, of authorized and unissued shares, treasury shares or shares purchased in the open market or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Eligibility. Participants in this Plan shall consist of Employees and Nonemployee
Director and persons expected to become Employees and Nonemployee Directors as the Committee in its sole discretion may select from time to time, provided that only Employees shall be eligible to receive grants of Incentive Stock Options. The
Committee&#146;s selection of a person to participate in this Plan at any time shall not require the Committee to select such person to participate in this Plan at any other time. Except as provided otherwise in an Award Agreement, for purposes of
this Plan, references to employment by the Company shall also mean employment by a Subsidiary, and references to employment shall include service as a Nonemployee Director. The Committee shall determine, in its sole discretion, the extent to which a
Participant shall be considered employed during any periods during which such Participant is on a leave of absence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. Plan
Administration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1. <I>Board Committee Administration. </I>This Plan shall be administered by the Committee. The Committee shall,
subject to the terms of this Plan, select eligible persons for participation in this Plan and determine the form, amount and timing of each Award to such persons and, if applicable, the number of Shares subject to an Award, the number of Stock
Appreciation Rights, the number of Restricted Share Units and Performance Units, the dollar value subject to a Performance Cash Award, the Option Price, Base Price or any other purchase price associated with the Award, the time and conditions of
exercise or settlement of the Award and all other terms and conditions of the Award, including, without limitation, the form of the Award Agreement. The Committee may, in its sole discretion and for any reason at any time, take action such that
(i)&nbsp;any or all outstanding Options and Stock Appreciation Rights shall become exercisable in part or in full, (ii)&nbsp;all or a portion of the vesting conditions applicable to any outstanding Awards shall lapse, (iii)&nbsp;all or a portion of
the Performance Period applicable to any outstanding Awards shall lapse and (iv)&nbsp;the Performance Objectives (if any) applicable to any outstanding Awards shall be deemed to be satisfied at the target, maximum or any other level. The Committee
shall, subject to the terms of this Plan, interpret this Plan and the application thereof, establish rules and regulations it deems necessary or desirable for the administration of this Plan and may impose, incidental to the grant of an Award,
conditions with respect to the award, such as restrictive covenants. All such interpretations, rules, regulations and conditions shall be conclusive and binding on all parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2. <I>Committee Delegation. </I>The Committee may delegate some or all of its power and authority hereunder to the Board or, subject to
applicable law, to a subcommittee of the Board, a member of the Board, the Chief Executive Officer or such other officer of the Company as the Committee deems appropriate, provided that the Committee shall have fixed the total number of Shares with
respect to delegations with respect to granting Awards; provided, however, that the Committee may not delegate its power and authority to a member of the Board or the Chief Executive Officer or other officer of the Company with regard to the
selection for participation in this Plan of an Employee or Nonemployee Director subject to Section&nbsp;16 of the Exchange Act or decisions concerning the timing, pricing or amount of an award to such Employee or Nonemployee Director. Any delegation
pursuant to this Section&nbsp;5.2 shall be subject to the limitations of the Kentucky Business Corporation Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3. <I>Limitation of Liability.</I><I> </I>No member of the Board or Committee, and neither
the Chief Executive Officer nor any other officer to whom the Committee delegates any of its power and authority hereunder, shall be liable for any act, omission, interpretation, construction or determination made in connection with this Plan in
good faith, and the members of the Board and the Committee and the Chief Executive Officer or other officer shall be entitled to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including
attorneys&#146; fees) arising therefrom to the full extent permitted by law (except as otherwise may be provided in the Company&#146;s Articles of Incorporation and/or Bylaws) and under any directors&#146; and officers&#146; liability insurance that
may be in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <I>Options.</I> The Committee may from time to time authorize grants to Participants of Options to
purchase Shares upon such terms and conditions as the Committee may determine in accordance with the following provisions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1. <I>Number
of Shares. </I>Each grant shall specify the number of Shares to which it pertains. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2. <I>Option Price. </I>Other than with respect to a
Substitute Award, each grant shall specify an Option Price per Share, which shall be equal to or greater than the Fair Market Value per Share on the Grant Date. With respect to an Option granted as a Substitute Award, which substitution occurs in
connection with a transaction to which Code Section&nbsp;424(a) or Code Section&nbsp;409A is applicable, the exercise price may be computed in accordance with such Code Sections and the regulations thereunder and the Option may contain such other
terms and conditions as the Committee may prescribe to cause such substitute Option to contain as nearly as possible the same terms and conditions (including the applicable vesting and termination provisions) as those contained in the previously
issued option being replaced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3. <I>Vesting.</I> Each Option grant may specify (i)&nbsp;a period of continuous employment of the
Optionee by the Company or any Subsidiary (or, in the case of a Nonemployee Director, service on the Board) that is necessary or (ii)&nbsp;Performance Objectives that must be achieved before the Options or installments thereof shall become
exercisable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4. <I>ISOs. </I>Options granted under this Plan may be Incentive Stock Options, Nonqualified Stock Options or a
combination of the foregoing, provided that only Nonqualified Stock Options may be granted to Nonemployee Directors. Each grant shall specify whether (or the extent to which) the Option is an Incentive Stock Option or a Nonqualified Stock Option.
Each Option, or portion thereof, that is not an Incentive Stock Option (including as a result of the failure to qualify as an Incentive Stock Option) shall be a Nonqualified Stock Option. Notwithstanding any such designation, to the extent that the
aggregate Fair Market Value of the Shares with respect to which Options designated as Incentive Stock Options are exercisable for the first time by an Optionee during any calendar year (under all plans of the Company) exceeds $100,000 (or such other
limit specified in the Code), such Options shall be treated as Nonqualified Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5. <I>Exercise Period. </I>No Option granted
under this Plan may be exercised more than ten years from the Grant Date; provided however, that if an Incentive Stock Option shall be granted to any person who, at the time such Incentive Stock Option is granted, owns capital stock
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
possessing more than 10&nbsp;percent of the total combined voting power of all classes of capital stock of the Company (or of any parent or Subsidiary), such Option shall not be exercised later
than five years after the Grant Date. Notwithstanding the foregoing, in the event that on the last business day of the term of an Option (i)&nbsp;the exercise of the Option, other than an Incentive Stock Option, is prohibited by applicable law or
(ii)&nbsp;Shares may not be purchased or sold by certain employees or directors of the Company due to the <FONT STYLE="white-space:nowrap">&#147;black-out</FONT> period&#148; of a Company policy or a
<FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement undertaken in connection with an issuance of securities by the Company, the term shall be extended for a period of thirty (30)&nbsp;days following the end of the legal
prohibition, <FONT STYLE="white-space:nowrap">black-out</FONT> period or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement to the extent such extension does not cause adverse tax consequences to the Participant under Section&nbsp;409A of the
Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6. <I>Award Agreement. </I>Each grant shall be evidenced by an Award Agreement containing such terms and provisions as the
Committee may determine consistent with this Plan. All terms relating to the exercise, cancellation or other disposition of an Option (i)&nbsp;upon a termination of employment with or service to the Company of the Optionee, whether by reason of
disability, retirement, death or any other reason, or (ii)&nbsp;during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.7. <I>Method of Exercise.</I> An Option may be exercised (i)&nbsp;by giving written notice to the Company specifying the number of whole
Shares to be purchased and accompanying such notice with payment therefor in full (or arrangement made for such payment to the Company&#146;s satisfaction) either (A)&nbsp;in cash, (B)&nbsp;by delivery (either actual delivery or by attestation
procedures established by the Company) of Shares having a Fair Market Value, determined as of the date of exercise, equal to the aggregate Option Price payable by reason of such exercise, (C)&nbsp;authorizing the Company to withhold whole Shares
which would otherwise be delivered having an aggregate Fair Market Value, determined as of the date of exercise, equal to the amount necessary to satisfy such obligation, (D)&nbsp;in cash by a broker-dealer acceptable to the Company to whom the
optionee has submitted an irrevocable notice of exercise, or (E)&nbsp;such other form of payment approved by the Committee, in each case to the extent set forth in the Award Agreement, (ii)&nbsp;if applicable, by surrendering to the Company any
Tandem Stock Appreciation Rights which are cancelled by reason of the exercise of the Option and (iii)&nbsp;by executing such documents as the Company may reasonably request. No Shares shall be issued and no certificate representing Shares shall be
delivered until the full Option Price therefor and any withholding taxes thereon, as described in Section&nbsp;16, have been paid (or arrangement made for such payment to the Company&#146;s satisfaction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.8. <I>No Dividend Equivalents.</I> Notwithstanding anything in an Award Agreement to the contrary, an Optionee shall not be entitled to
receive dividend equivalents with respect to the number of Shares subject to such Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <I>Stock Appreciation Rights.</I> The
Committee may also authorize grants to Participants of Stock Appreciation Rights. A Stock Appreciation Right is the right of the Participant to receive from the Company an amount, which shall be determined by the Committee and shall be expressed as
a percentage (not exceeding 100 percent) of the Spread at the time of the exercise of such right. Any grant of Stock Appreciation Rights under this Plan shall be upon such terms and conditions as the Committee may determine in accordance with the
following provisions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1. <I>Payment in Cash or Shares. </I>Any grant may specify that the amount payable upon
the exercise of a Stock Appreciation Right may be paid by the Company in cash, Shares or any combination thereof as specified in the Award agreement and may (i)&nbsp;either grant to the Participant or reserve to the Committee the right to elect
among those alternatives or (ii)&nbsp;preclude the right of the Participant to receive and the Company to issue Shares or other equity securities in lieu of cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2. <I>Maximum SAR Payment. </I>Any grant may specify that the amount payable upon the exercise of a Stock Appreciation Right shall not
exceed a maximum amount specified by the Committee on the Grant Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3. <I>Vesting.</I> Each Stock Appreciation Rights grant may
specify (i)&nbsp;a period of continuous employment of the Participant by the Company or any Subsidiary (or, in the case of a Nonemployee Director, service on the Board) that is necessary or (ii)&nbsp;Performance Objectives that must be achieved
before the Stock Appreciation Rights or installments thereof shall become exercisable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4. <I>Exercise Period. </I>Any grant may specify
(i)&nbsp;a waiting period or periods before Stock Appreciation Rights shall become exercisable and (ii)&nbsp;permissible dates or periods on or during which Stock Appreciation Rights shall be exercisable. No Stock Appreciation Right granted under
this Plan may be exercised more than ten years from the Grant Date. Notwithstanding the foregoing, in the event that on the last business day of the term of a Stock Appreciation Right (x)&nbsp;the exercise of the Stock Appreciation Right is
prohibited by applicable law or (y)&nbsp;Shares may not be purchased or sold by certain employees or directors of the Company due to the <FONT STYLE="white-space:nowrap">&#147;black-out</FONT> period&#148; of a Company policy or a <FONT
STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreement undertaken in connection with an issuance of securities by the Company, the term shall be extended for a period of thirty (30)&nbsp;days following the end of the legal prohibition, <FONT
STYLE="white-space:nowrap">black-out</FONT> period or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement to the extent such extension does not cause adverse tax consequences to the Participant under Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5. <I>Award Agreement. </I>Each grant shall be evidenced by an Award Agreement which shall describe the subject Stock Appreciation Rights,
identify any related Options, state that the Stock Appreciation Rights are subject to all of the terms and conditions of this Plan and contain such other terms and provisions as the Committee may determine consistent with this Plan. All terms
relating to the exercise, cancellation or other disposition of a Stock Appreciation Right (i)&nbsp;upon a termination of employment with or service to the Company of the Participant, whether by reason of disability, retirement, death or any other
reason, or (ii)&nbsp;during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6. <I>Tandem Stock Appreciation Rights. </I>Each grant of a Tandem Stock Appreciation Right shall provide that such Tandem Stock
Appreciation Right may be exercised only (i)&nbsp;at a time when the related Option (or any similar right granted under any other plan of the Company) is also exercisable and the Spread is positive; and (ii)&nbsp;by surrender of the related Option
(or such other right) for cancellation. The exercise price of a Tandem SAR shall be the Option Price per Share of the related Option. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7. <I>Freestanding Stock Appreciation Rights. </I>Regarding Freestanding Stock
Appreciation Rights only, each grant shall specify in respect of each Freestanding Stock Appreciation Right a Base Price per Share, which shall be equal to or greater than the Fair Market Value on the Grant Date except in the case of Freestanding
Stock Appreciation Rights granted as a Substitute Award.&#8195;With respect to a Freestanding Stock Appreciation Right granted as a Substitute Award, which substitution occurs in connection with a transaction to which Code Section&nbsp;409A is
applicable, the exercise price may be computed in accordance with such Code Section&nbsp;409A and the regulations thereunder and the Freestanding Stock Appreciation Right may contain such other terms and conditions as the Committee may prescribe to
cause such substitute Freestanding Stock Appreciation Right to contain as nearly as possible the same terms and conditions (including the applicable vesting and termination provisions) as those contained in the previously issued stock appreciation
right being replaced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.8. <I>Method of Exercise.</I> A Tandem Stock Appreciation Right may be exercised (i)&nbsp;by giving written
notice to the Company specifying the number of whole Stock Appreciation Rights which are being exercised, (ii)&nbsp;by surrendering to the Company any Options which are cancelled by reason of the exercise of the Tandem Stock Appreciation Right and
(iii)&nbsp;by executing such documents as the Company may reasonably request. A Freestanding Stock Appreciation Right may be exercised (A)&nbsp;by giving written notice to the Company specifying the whole number of Freestanding Stock Appreciation
Right which are being exercised and (B)&nbsp;by executing such documents as the Company may reasonably request. No Shares shall be issued and no certificate representing Shares shall be delivered until any withholding taxes thereon, as described in
Section&nbsp;16, have been paid (or arrangement made for such payment to the Company&#146;s satisfaction). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.9. <I>No Dividend
Equivalents.</I> Notwithstanding anything in an Award Agreement to the contrary, a Participant shall not be entitled to receive dividend equivalents with respect to the number of Shares subject to a Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <I>Restricted Shares. </I>The Committee may authorize grants to Participants of Restricted Shares upon such terms and conditions as the
Committee may determine in accordance with the following provisions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1. <I>Number of Shares and Other Terms.</I> The number of Shares
subject to a Restricted Share Award and the vesting period, Performance Period (if any) and Performance Objectives (if any) applicable to a Restricted Share Award shall be determined by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2. <I>Vesting and Forfeiture.</I> The Award Agreement relating to a Restricted Share Award shall provide, in the manner determined by the
Committee, in its discretion, and subject to the provisions of this Plan, for the vesting of the Shares subject to such award (i)&nbsp;if the Participant remains continuously in the employment of the Company or any Subsidiary (or, in the case of a
Nonemployee Director, service on the Board) during the specified vesting period and (ii)&nbsp;if specified Performance Objectives (if any) are satisfied or met during a specified Performance Period, and for the forfeiture of the Shares subject to
such Award (x)&nbsp;if the Participant does not remain continuously in the employment of the Company or any Subsidiary (or, in the case of a Nonemployee Director, service on the Board) during the specified vesting
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
period or (y)&nbsp;if specified Performance Objectives (if any) are not satisfied or met during a specified Performance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3. <I>Transfer of Shares. </I>Each grant shall constitute an immediate transfer of the ownership of Shares to the Participant, with
restrictions on such Shares duly noted, in consideration of the performance of services, subject to vesting and forfeiture and restrictions on transfer hereinafter referred to. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4. <I>Dividends, Voting and Other Ownership Rights. </I>Unless otherwise determined by the Committee, an Award of Restricted Shares shall
entitle the Participant to dividend, capitalization adjustments applicable to all holders of Shares, voting and other ownership rights during the period for which such substantial risk of forfeiture is to continue; provided, however, that any
dividend or other distribution paid with respect to Shares subject to a Restricted Share Award shall be deposited with the Company and shall be subject to the same restrictions as the Shares with respect to which such dividend or distribution was
made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5. <I>Restrictions on Transfer. </I>Each grant shall provide that, during the period for which such substantial risk of
forfeiture is to continue, the transferability of the Restricted Shares shall be prohibited or restricted in the manner and to the extent prescribed by the Committee on the Grant Date. Such restrictions may include, without limitation, rights of
repurchase or first refusal in the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6. <I>Award Agreements. </I>Each grant shall be evidenced by an Award Agreement containing
such terms and provisions as the Committee may determine consistent with this Plan. Unless otherwise directed by the Committee, all certificates representing Restricted Shares, together with a stock power that shall be endorsed in blank by the
Participant with respect to such Shares, shall be held in custody by the Company until all restrictions thereon lapse. All of the terms relating to the satisfaction of Performance Objectives (if any) and the termination of the vesting period or
Performance Period relating to a Restricted Share Award, or any forfeiture and cancellation of such Award (i)&nbsp;upon a termination of employment with or service to the Company or any Subsidiary of the Participant, whether by reason of disability,
retirement, death or any other reason, or (ii) during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the applicable Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <I>Restricted Share Units. </I>The Committee may authorize grants of Restricted Share Units to Participants upon such terms and conditions
as the Committee may determine in accordance with the following provisions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1. <I>Number of Shares and Other Terms.</I> The number of
Shares subject to a Restricted Share Unit Award and the vesting period, Performance Period (if any) and Performance Objectives (if any) applicable to a Restricted Share Unit Award shall be determined by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2. <I>Deferred Compensation. </I>Each grant shall constitute the agreement by the Company to issue or transfer Shares or, to the extent set
forth in the Award Agreement, the Fair Market Value of such Shares in cash, to the Participant in the future in consideration of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance of services, subject to the fulfillment during the Deferral Period of such conditions as the Committee may specify. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3. <I>Deferral Period. </I>Each grant shall provide that the Restricted Share Units covered thereby shall be subject to a Deferral Period,
which shall be fixed by the Committee on the Grant Date and which may lapse if (i)&nbsp;the Participant remains continuously in the employment of the Company or any Subsidiary (or, in the case of a Nonemployee Director, service on the Board) during
the Deferral Period and (ii)&nbsp;if specified Performance Objectives (if any) are satisfied or met during a specified Performance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4. <I>Dividend Equivalents and Other Ownership Rights. </I>During the Deferral Period, the Participant shall not have any right to transfer
any rights under the subject Award, shall not have any rights of ownership in the Restricted Share Units and shall not have any right to vote such shares, but the Committee may on or after the Grant Date authorize the payment of dividend equivalents
on such shares in cash or additional Shares on a current, deferred or contingent basis. Notwithstanding anything contained herein to the contrary, dividend equivalents on Restricted Share Units shall be subject to the same vesting and other
restrictions as the Restricted Share Units to which they relate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5. <I>Award Agreement. </I>Each grant shall be evidenced by an Award
Agreement containing such terms and provisions as the Committee may determine consistent with this Plan. All of the terms relating to the satisfaction of Performance Objectives (if any) and the termination of the Deferral Period or Performance
Period relating to a Restricted Share Unit Award, or any forfeiture and cancellation of such Award (i)&nbsp;upon a termination of employment with or service to the Company or any Subsidiary of the Participant, whether by reason of disability,
retirement, death or any other reason, or (ii)&nbsp;during a paid or unpaid leave of absence, shall be determined by the Committee and set forth in the applicable Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <I>Performance Awards. </I>The Committee may authorize grants of Performance Shares, Performance Units and Performance Cash, which shall
become payable to the Participant upon the achievement of specified Performance Objectives, upon such terms and conditions as the Committee may determine in accordance with the following provisions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1. <I>Number of Performance Shares or Units; Amount of Performance Cash. </I>Each grant shall specify the number of Performance Shares or
Performance Units, or amount of Performance Cash, to which it pertains. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2. <I>Performance Period. </I>The Performance Period with
respect to each Performance Award shall commence on the Grant Date or such other date as the Committee determines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3. <I>Performance
Objectives. </I>Each grant shall specify the Performance Objectives that are to be achieved by the Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.4. <I>Threshold
Performance Objectives. </I>Each grant may specify in respect of the specified Performance Objectives a minimum acceptable level of achievement below which no payment will be made and may set forth a formula for determining the amount of any payment
to be made if performance is at or above such minimum acceptable level but falls short of the maximum achievement of the specified Performance Objectives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.5. <I>Payment of Performance Awards. </I>Each grant shall specify the time and manner of
payment of Performance Awards that shall have been earned, and any grant may specify that any such amount may be paid by the Company in cash, Shares or any combination thereof as specified in the Award agreement and may either grant to the
Participant or reserve to the Committee the right to elect among those alternatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.6. <I>Dividend Equivalents. </I>Any grant of a
Performance Award may provide for the payment to the Participant of dividend equivalents thereon in cash or additional Shares. Notwithstanding anything contained herein to the contrary, dividend equivalents on Performance Awards shall be subject to
the same vesting and other restrictions as the Performance Awards to which they relate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.7. <I>Award Agreement. </I>Each grant shall be
evidenced by an Award Agreement which shall state that the Performance Shares, Performance Units or Performance Cash, as applicable, are subject to all of the terms and conditions of this Plan and such other terms and provisions as the Committee may
determine consistent with this Plan. All of the terms relating to the satisfaction of Performance Objectives and the termination of the vesting period or Performance Period relating to a Performance Award, or any forfeiture and cancellation of such
Award (i)&nbsp;upon a termination of employment with or service to the Company or any Subsidiary of the Participant, whether by reason of disability, retirement, death or any other reason, or (ii)&nbsp;during a paid or unpaid leave of absence, shall
be determined by the Committee and set forth in the applicable Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <I>Other Share-Based Awards.</I> The Committee may
authorize grants of Other-Share Based Awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares, including without limitation Shares granted as a bonus and not subject to
any vesting conditions, dividend equivalents, share purchase rights and Shares issued in lieu of obligations of the Company to pay cash under any compensatory plan or arrangement, subject to such terms as shall be determined by the Committee. The
Committee shall determine the terms and conditions of such awards, which may include the right to elective deferral thereof, subject to such terms and conditions as the Committee may specify in its discretion. Any distribution, dividend or dividend
equivalents with respect to Other Share-Based Awards that are subject to vesting conditions shall be subject to the same vesting conditions as the underlying awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">12. Transferability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1.
<I>Transfer Restrictions. </I>Except as provided in Section&nbsp;12.2, no Award granted under this Plan shall be transferable by a Participant other than by will or the laws of descent and distribution, and Options and Stock Appreciation Rights
shall be exercisable during a Participant&#146;s lifetime only by the Participant or, in the event of the Participant&#146;s legal incapacity, by his guardian or legal representative acting in a fiduciary capacity on behalf of the Participant under
state law. Any attempt to transfer an Award in violation of this Plan shall render such Award null and void. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2. <I>Limited Transfer Rights. </I>The Committee may expressly provide in an Award
Agreement (or an amendment to an Award Agreement) that a Participant may transfer without consideration such Award (other than an Incentive Stock Option), in whole or in part, to a spouse or lineal descendant (a &#147;<I>Family</I><I>
Member&#148;),</I> a trust for the exclusive benefit of Family Members, a partnership or other entity in which all the beneficial owners are Family Members, or any other entity affiliated with the Participant that may be approved by the Committee.
Subsequent transfers of Awards shall be prohibited except in accordance with this Section&nbsp;12.2. All terms and conditions of the Award, including provisions relating to the termination of the Participant&#146;s employment or service with the
Company or a Subsidiary, shall continue to apply following a transfer made in accordance with this Section&nbsp;12.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.3.
<I>Restrictions on Transfer. </I>Any Award made under this Plan may provide that all or any part of the Shares that are to be issued or transferred by the Company upon the exercise or settlement of an Award, as applicable, shall be subject to
further restrictions upon transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.4. <I>Designation of Beneficiary.</I> To the extent permitted by the Company, a holder of an Award
may file with the Company a written designation of one or more persons as such holder&#146;s beneficiary or beneficiaries (both primary and contingent) in the event of the holder&#146;s death or incapacity. To the extent an outstanding Option or
Stock Appreciation Right granted hereunder is exercisable, such beneficiary or beneficiaries shall be entitled to exercise such Option or Stock Appreciation Right pursuant to procedures prescribed by the Company. Each beneficiary designation shall
become effective only when filed in writing with the Company during the holder&#146;s lifetime on a form prescribed by the Company. The spouse of a married holder domiciled in a community property jurisdiction shall join in any designation of a
beneficiary other than such spouse. The filing with the Company of a new beneficiary designation shall cancel all previously filed beneficiary designations. If a holder fails to designate a beneficiary, or if all designated beneficiaries of a holder
predecease the holder, then each outstanding award held by such holder, to the extent vested or exercisable, shall be payable to or may be exercised by such holder&#146;s executor, administrator, legal representative or similar person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <I>Adjustments.</I> In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting
Standards Codification Topic 718, Compensation&#151;Stock Compensation, or any successor or replacement accounting standard) that causes the per share value of Shares to change, such as a share dividend, share split, spinoff, rights offering or
recapitalization through an extraordinary cash dividend, the number and class of securities available under this Plan, the terms of each outstanding Option and Stock Appreciation Right (including the number and class of securities subject to each
outstanding Option or Stock Appreciation Right and the Option Price or Base Price per Share), the terms of each outstanding Restricted Share Award, Restricted Share Unit Award and Other Share-Based Award (including the number and class of securities
subject thereto), and the terms of each outstanding Performance Award (including the number and class of securities subject thereto) shall be appropriately adjusted by the Committee, such adjustments to be made in the case of outstanding Options and
Stock Appreciation Rights in accordance with Section&nbsp;409A of the Code. In the event of any other change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete liquidation of the Company, such
equitable adjustments described in the foregoing sentence may be made as determined to be appropriate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and equitable by the Committee to prevent dilution or enlargement of rights of participants. In either case, the decision of the Committee regarding any such adjustment shall be final, binding
and conclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <I>Fractional Shares.</I> The Company shall not be required to issue any fractional Shares pursuant to this Plan. The
Committee may provide for the elimination of fractions or for the settlement thereof in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. Change in Control Provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.1. <I>Impact on Certain Awards.</I> Unless otherwise provided in an Award Agreement, the Committee (as constituted prior to the Change in
Control) shall have the right to provide in the event of a Change in Control: (i)&nbsp;Options and Stock Appreciation Rights outstanding as of the date of the Change in Control shall be cancelled and terminated without payment if the Fair Market
Value of one Share as of the date of the Change in Control is less than the per Share Option Price or Base Price; and (ii)&nbsp;all Performance Awards shall be (x)&nbsp;considered to be earned and payable based on achievement of performance goals,
target performance or such other performance level determined by the Committee (either in full or pro rata based on the portion of Performance Period completed as of the date of the Change in Control), and any limitations or other restrictions shall
lapse and such Performance Awards shall be immediately settled or distributed or (y)&nbsp;converted into Restricted Share or Restricted Share Unit Awards based on achievement of performance goals, target performance or such other performance level
determined by the Committee (either in full or pro rata based on the portion of Performance Period completed as of the date of the Change in Control) that are subject to Section&nbsp;15.2 and with appropriate adjustments in accordance with
Section&nbsp;13. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.2. <I>Assumption or Substitution of Certain Awards.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Unless otherwise provided in an Award Agreement, in the event of a Change in Control in which the successor company assumes or substitutes
shares of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change in Control, or a parent corporation thereof, for some or all of the Shares subject to an outstanding Award, with an
appropriate and equitable adjustment to such Award as determined by the Committee (as constituted prior to the Change in Control) in accordance with Section&nbsp;13, if a Participant&#146;s employment with such successor company (or the Company) or
a subsidiary thereof terminates within 24 months following such Change in Control (or such other period set forth in the Award Agreement, including prior thereto if applicable) and under the circumstances specified in the Award Agreement:
(i)&nbsp;Options and Stock Appreciation Rights outstanding as of the date of such termination of employment will immediately vest, become fully exercisable and shall remain exercisable for a <FONT STYLE="white-space:nowrap">two-year</FONT> period
(or if earlier, until the original expiration date set forth in the Award Agreement); (ii) the restrictions, limitations and other conditions applicable to Restricted Shares, Restricted Share Units and Other Share-Based Awards outstanding as of the
date of such termination of employment shall lapse and the Restricted Shares, Restricted Share Units and Other Share-Based Awards shall become free of all restrictions, limitations and conditions and become fully vested; and (iii)&nbsp;the
restrictions, limitations and other conditions applicable to any other Awards shall lapse, and such other Awards shall become free of all restrictions, limitations and conditions and become fully vested and transferable. For the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purposes of this Section&nbsp;15.2, an Award shall be considered assumed or substituted for if, following the Change in Control, the Award confers the right to purchase or receive, for each Share
subject to the Award immediately prior to the Change in Control, the consideration (whether shares, cash or other securities or property) received in the transaction constituting a Change in Control by holders of Shares for each Share held on the
effective date of such transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares), with appropriate adjustments in accordance with Section&nbsp;13;
provided, however, that if such consideration received in the transaction constituting a Change in Control is not solely common stock of the successor company, the Committee may, with the consent of the successor company, provide that the
consideration to be received upon the exercise or vesting of an Award, for each Share subject thereto, will be solely common stock of the successor company with a fair market value substantially equal to the per Share consideration received by
holders of Shares in the transaction constituting a Change in Control. The determination of what fair market value is substantially equal shall be made by the Committee, as constituted prior to the Change in Control, in its sole discretion and its
determination shall be conclusive and binding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Unless otherwise provided in an Award Agreement, in the event of a Change in Control,
to the extent the successor company does not assume or substitute for an Award (or in which the Company is the ultimate parent corporation and does not continue the Award), then immediately prior to the Change in Control: (i)&nbsp;Options and Stock
Appreciation Rights outstanding as of the date of the Change in Control that are not assumed or substituted for (or continued) shall immediately vest and become fully exercisable; (ii)&nbsp;restrictions, limitations and other conditions applicable
to Awards that are not assumed or substituted for (or continued) shall lapse and the Awards shall become free of all restrictions, limitations and conditions and become fully vested; and (iii)&nbsp;the restrictions, other limitations and other
conditions applicable to any other Awards that are not assumed or substituted for (or continued) shall lapse, and such other Awards shall become free of all restrictions, limitations and conditions and become fully vested and transferable and the
Committee (as constituted prior to the Change in Control) may require such Awards, in its discretion and in whole or in part, to be surrendered to the Company by the Participant, and to be immediately cancelled by the Company, and to provide for the
Participant to receive (A)&nbsp;a cash payment or other property in an amount equal to (1)&nbsp;in the case of an Option or Stock Appreciation Right, the aggregate number of Shares then subject to the portion of such Option or Stock Appreciation
Right surrendered multiplied by the excess, if any, of the Fair Market Value of a Share as of the date of the Change in Control, over the Option Price or Base Price per Share subject to such Option or Stock Appreciation Right, (2)&nbsp;in the case
of Restricted Shares, Restricted Share Units, Other Share-Based Awards or Performance Awards denominated in Shares, the aggregate number of Shares then subject to the portion of such Award surrendered to the extent the Performance Objectives
applicable to such Award have been satisfied or are deemed satisfied pursuant to Section&nbsp;15.1, multiplied by the Fair Market Value of a Share as of the date of the Change in Control, and (3)&nbsp;in the case of an Performance Award denominated
in cash, the value of the Performance Award then subject to the portion of such Award surrendered to the extent the Performance Objectives applicable to such Award have been satisfied or are deemed satisfied pursuant to Section&nbsp;15.1; (B) shares
of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change in Control, or a parent corporation thereof, having a fair market value not less than the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amount determined under clause (A)&nbsp;above; or (C)&nbsp;a combination of the payment of cash or other property pursuant to clause (A)&nbsp;above and the issuance of shares pursuant to clause
(B)&nbsp;above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <I>Withholding Taxes.</I> The Company shall have the right to require, prior to the issuance or delivery of any
Shares or the payment of any cash pursuant to an Award made hereunder, payment by the holder of such Award of any federal, state, local or other taxes which may be required to be withheld or paid in connection with such Award. An Award Agreement may
provide that (i)&nbsp;the Company shall withhold whole Shares which would otherwise be delivered to a holder, having an aggregate Fair Market Value determined as of the date the obligation to withhold or pay taxes arises in connection with an Award
(the &#147;<I>Tax</I><I> Date&#148;),</I> or withhold an amount of cash which would otherwise be payable to a holder, in the amount necessary to satisfy any such obligation or (ii)&nbsp;the holder may satisfy any such obligation by any of the
following means: (A)&nbsp;a cash payment to the Company; (B)&nbsp;delivery (either actual delivery or by attestation procedures established by the Company) to the Company of previously owned whole Shares having an aggregate Fair Market Value,
determined as of the Tax Date, equal to the amount necessary to satisfy any such obligation; (C)&nbsp;authorizing the Company to withhold whole Shares which would otherwise be delivered having an aggregate Fair Market Value, determined as of the Tax
Date, or withhold an amount of cash which would otherwise be payable to a holder, equal to the amount necessary to satisfy any such obligation; (D)&nbsp;a cash payment by a broker-dealer acceptable to the Company to whom the participant has
submitted an irrevocable notice of exercise or sale or (E)&nbsp;such other form of payment approved by the Committee, in each case to the extent set forth in the Award Agreement. Shares to be delivered or withheld may not have an aggregate Fair
Market Value in excess of the amount determined by applying the minimum statutory withholding rate (or, if permitted by the Company, such other rate as will not cause adverse accounting consequences under the accounting rules then in effect, and is
permitted under applicable IRS withholding rules); provided, however, that if a fraction of a Share would be required to satisfy the minimum statutory withholding taxes, then the number of Shares to be delivered or withheld may be rounded up to the
next nearest whole Share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <I>Foreign Participants.</I> In order to facilitate the making of any grant or combination of grants under
this Plan, the Committee may provide for such special terms for Awards to Participants who are foreign nationals, or who are employed by or perform services for the Company or any Subsidiary outside of the United States of America, as the Committee
may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee may approve such supplements to, or amendments, restatements or alternative versions of, this Plan as it may consider
necessary or appropriate for such purposes without thereby affecting the terms of this Plan as in effect for any other purpose, provided that no such supplements, amendments, restatements or alternative versions shall include any provisions that are
inconsistent with the terms of this Plan, as then in effect, unless this Plan could have been amended to eliminate such inconsistency without further approval by the stockholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. Amendments and Other Matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.1. <I>Plan Amendments. </I>This Plan may be amended from time to time by the Board, but no such amendment shall (a)&nbsp;materially impair
the rights of a Participant with respect to a previously granted Award without the Participant&#146;s consent, except with respect to an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amendment that is necessary to be made in order to comply with applicable law, stock exchanges rules or accounting rules or (b)&nbsp;increase any of the limitations specified in Section&nbsp;3,
other than to reflect an adjustment made in accordance with Section&nbsp;13, or modify the prohibition on repricing contained in Section&nbsp;18.4, without the further approval of the stockholders of the Company. The Board may condition any
amendment on the approval of the stockholders of the Company if such approval is necessary or deemed advisable with respect to the applicable listing or other requirements of a national securities exchange or other applicable laws, policies or
regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.2. <I>Award Deferrals. </I>The Committee may permit Participants to elect to defer the issuance of Shares or the
settlement of Awards in cash under the Plan pursuant to such rules, procedures or programs as it may establish for purposes of this Plan. In the case of an award of Restricted Shares, the deferral may be effected by the Participant&#146;s agreement
to forego or exchange his or her award of Restricted Shares and receive an award of Restricted Share Units. The Committee also may provide that deferred settlements include the payment or crediting of interest on the deferral amounts, or the payment
or crediting of dividend equivalents where the deferral amounts are denominated in Shares, provided that any dividend equivalents shall be subject to the same vesting conditions as the underlying Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.3. <I>Conditional Awards. </I>Subject to Section&nbsp;18.4, the Committee may condition the grant of any award or combination of Awards
under the Plan on the surrender or deferral by the Participant of his or her right to receive a cash bonus or other compensation otherwise payable by the Company or any Subsidiary to the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.4. <I>Repricing Prohibited. </I>The Committee shall not, without the approval of the Company&#146;s stockholders, (a)&nbsp;lower the Option
Price or Base Price per Share of an Option or Stock Appreciation Right after it is granted, (b)&nbsp;cancel any previously granted Option or Stock Appreciation Right in exchange for another Option or Stock Appreciation Right with a lower Option
Price or Base Price, (c)&nbsp;cancel an Option or Stock Appreciation Right when the exercise price per Share exceeds the Fair Market Value of one Share in exchange for cash or another Award, or (d)&nbsp;take any other action with respect to an
Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal U.S. national securities exchange on which the Shares are listed, in each case, other than in connection with a Change in
Control or the adjustment provisions set forth in Section&nbsp;13. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.5. <I>No Right of Participation, Employment or Service. </I>Unless
otherwise set forth in an employment agreement, no person shall have any right to participate in this Plan. This Plan shall not confer upon any Participant any right with respect to continuance of employment or other service with the Company or any
Subsidiary and shall not interfere in any way with any right that the Company or any Subsidiary would otherwise have to terminate any Participant&#146;s employment or other service at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.6. <I>Rights as a Stockholder.</I> No person shall have any right as a stockholder of the Company with respect to any Shares or other
equity security of the Company which is subject to an Award hereunder unless and until such person becomes a stockholder of record with respect to such Shares or equity security. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.7. <I>Restrictions on Shares.</I> Each Award made hereunder shall be subject to the
requirement that if at any time the Company determines that the listing, registration or qualification of the Shares subject to such Award upon any securities exchange or under any law, or the consent or approval of any governmental body, or the
taking of any other action is necessary or desirable as a condition of, or in connection with, the delivery of shares thereunder, such Shares shall not be delivered unless such listing, registration, qualification, consent, approval or other action
shall have been effected or obtained, free of any conditions not acceptable to the Company. The Company may require that certificates evidencing Shares delivered pursuant to any Award made hereunder bear a legend indicating that the sale, transfer
or other disposition thereof by the holder is prohibited except in compliance with the Securities Act of 1933, as amended, and the rules and regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.8. <I>Compliance with Section</I><I></I><I>&nbsp;409A of the Code. </I>Notwithstanding any provision of the Plan to the contrary, this Plan
is intended to comply with, or be exempt from, the applicable requirements of Section&nbsp;409A of the Code and shall be administered in a manner that is intended to comply with, or exempt from, Section&nbsp;409A of the Code and shall be construed
and interpreted in accordance with such intent. To the extent that an Award or the payment, settlement or deferral thereof is subject to Section&nbsp;409A of the Code, the Award shall be granted, paid, settled or deferred in a manner that will
comply with Section&nbsp;409A of the Code, including regulations or other guidance issued with respect thereto, except as otherwise determined by the<I> </I>Committee. Any provision of this Plan that would cause the grant of an Award or the payment,
settlement or deferral thereof to fail to satisfy Section&nbsp;409A of the Code shall be amended to comply with Section&nbsp;409A of the Code on a timely basis, which may be made on a retroactive basis, in accordance with regulations and other
guidance issued under Section&nbsp;409A of the Code. Each Participant is solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on or in respect of such Participant in connection with this Plan or any Award
(including any taxes or penalties under Section&nbsp;409A of the Code), and neither the Company nor any affiliate shall have any obligation to indemnify or otherwise hold such Participant (or any beneficiary) harmless from any or all of such taxes
or penalties. Notwithstanding anything in the Plan to the contrary, if a Participant is a &#147;specified employee&#148; within the meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code, no payments or deliveries in respect of any Awards that are
&#147;deferred compensation&#148; subject to Section&nbsp;409A of the Code and which are payable upon the Participant&#146;s &#147;separation from service&#148; (as defined in Section&nbsp;409A of the Code), shall be made to such Participant prior
to the date that is six months after the date of such Participant&#146;s &#147;separation from service&#148; or, if earlier, the Participant&#146;s date of death, to the extent required to comply with Section&nbsp;409A of the Code. Following any
applicable six month delay, all such delayed payments or deliveries will be paid or delivered (without interest) in a single lump sum on the earliest date permitted under Section&nbsp;409A of the Code that is also a business day. Unless otherwise
provided by the Committee, in the event that the timing of payments in respect of any Award (that would otherwise be considered &#147;deferred compensation&#148; subject to Section&nbsp;409A of the Code) would be accelerated upon the occurrence of
(A)&nbsp;a Change in Control, no such acceleration shall be permitted unless the event giving rise to the Change in Control satisfies the definition of a change in the ownership or effective control of a corporation, or a change in the ownership of
a substantial portion of the assets of a corporation pursuant to Section&nbsp;409A of the Code and any Treasury Regulations promulgated thereunder or (B)&nbsp;a disability, no such acceleration shall be permitted unless the disability also satisfies
the definition of &#147;Disability&#148; pursuant to Section&nbsp;409A of the Code and any Treasury Regulations promulgated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereunder. For purposes of Section&nbsp;409A of the Code, each payment made under this Plan or any Award shall be treated as a separate payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <I>Effective Date. </I>This Plan shall become effective upon its approval by the stockholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <I>Termination.</I> This Plan shall terminate on the tenth anniversary of the date upon which it is approved by the stockholders of the
Company (and, with respect to Incentive Stock Options, on the tenth anniversary of the date upon which it is approved by the Board), unless earlier terminated by the Board, and no Award shall be granted after that date. Termination of this Plan
shall not affect the terms or conditions of any award granted prior to termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <I>Recoupment of Awards.</I> The Awards granted
under this Plan and any cash payment or Shares delivered pursuant to an Award are subject to forfeiture, recovery by the Company or other action pursuant to the applicable Award Agreement or any clawback or recoupment policy which the Company may
adopt from time to time, including, without limitation, the Churchill Downs Incorporated Policy on Recoupment of Incentive Compensation, and any other policy which the Company may be required to adopt under the Dodd-Frank Wall Street Reform and
Consumer Protection Act and implementing rules and regulations thereunder, or as otherwise required by law or applicable listing standards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <I>Governing Law.</I> This Plan, each Award hereunder and the related Award Agreement, and all determinations made and actions taken
pursuant thereto, to the extent not otherwise governed by the Code or the laws of the United States, shall be governed by the laws of the Commonwealth of Kentucky and construed in accordance therewith without giving effect to principles of conflicts
of laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d902037dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;5.1 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g902037kjab.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">April&nbsp;<U>23</U>, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Churchill Downs Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">600 N. Hurstbourne Parkway, Suite 400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Louisville, Kentucky 40222
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;&#8195;&#8195;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Re:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Securities Registered under Registration Statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You have requested our opinion with respect to certain matters in connection with the filing by Churchill Downs Incorporated, a
Kentucky corporation (the &#147;<U>Company</U>&#148;) of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (as may be amended or supplemented, the &#147;<U>Registration Statement</U>&#148;) with the Securities and Exchange
Commission pursuant to the Securities Act of 1933, as amended (the &#147;<U>Act</U>&#148;) covering the offering of up to 3,300,000 shares of the Company&#146;s common stock, no par value (the &#147;<U>Shares</U>&#148;) pursuant to the Churchill
Downs Incorporated 2025 Omnibus Stock and Incentive Plan (the &#147;<U>Plan</U>&#148;). No opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement other than as to the validity of the Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have examined and are familiar with the Company, its organization and proceedings related thereto. We have also examined
such other documents and procedures as we have considered necessary for the purpose of this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have assumed, for
purposes of this opinion, that the Shares will be validly authorized on the respective dates of issuance of the Shares under the Plan, and that, on the dates of issuance of the Shares under the Plan, the obligations of the Company under the Plan
will constitute the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based upon the foregoing and subject to the qualifications hereinafter set forth, we are of the opinion that the Shares, when
issued and sold in accordance with the Registration Statement, the prospectus delivered to participants in the Plan pursuant to the requirements of the Act, the pertinent provisions of any applicable state securities laws and the Plan, will be duly
and validly issued, fully paid and nonassessable under the laws of the Commonwealth of Kentucky. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">710&nbsp;W<SMALL>EST</SMALL>&nbsp;M<SMALL>AIN</SMALL>&nbsp;S<SMALL>TREET</SMALL>,&nbsp;
4<SUP STYLE="font-size:75%; vertical-align:top">TH</SUP>&nbsp;F<SMALL>LOOR</SMALL>,&nbsp;L<SMALL>OUISVILLE</SMALL>,&nbsp;K<SMALL>ENTUCKY</SMALL>&nbsp;40202 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">T<SMALL>EL</SMALL>: <FONT STYLE="white-space:nowrap">(502)&nbsp;416-1630&#8195;&#8195;F</FONT><SMALL>AX</SMALL>:
<FONT STYLE="white-space:nowrap">(502)&nbsp;540-8282</FONT> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Churchill Downs Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">600
N. Hurstbourne Parkway, Suite 400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Louisville, Kentucky 40222 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We express no opinion with respect to Shares issuable under the Plans which are purchased by the Company on the open market or
in private transactions and are not original issuance shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are members of the Bar of the Commonwealth of Kentucky
and do not express any opinion herein concerning any law other than the laws of the Commonwealth of Kentucky. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This
opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We expressly disclaim any responsibility for advising
you of any change hereafter occurring in circumstances touching or concerning the transaction which is the subject of this opinion, including any changes in the law or in factual matters occurring subsequent to the date of this opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We hereby consent to the filing of this opinion, or copies thereof, as an Exhibit to the Registration Statement. In giving
this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Securities and Exchange Commission thereunder. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">/<SMALL>S</SMALL>/ K<SMALL>APLAN</SMALL> J<SMALL>OHNSON</SMALL> A<SMALL>BATE</SMALL>&nbsp;&amp; B<SMALL>IRD</SMALL>
LLP</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>d902037dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the incorporation by reference in this Registration Statement on Form<B></B><FONT STYLE="white-space:nowrap">&nbsp;S-8</FONT> of
Churchill Downs Incorporated<B> </B>of our report dated February&nbsp;19, 2025<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>relating to the financial statements, financial statement schedule and the effectiveness of internal control over
financial reporting, which appears in Churchill Downs Incorporated&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2024. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ PricewaterhouseCoopers LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Louisville, Kentucky </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;23, 2025 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>d902037dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
<title>EX-FILING FEES</title>
</head>
  <body> <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-116">S-8</ix:nonNumeric> <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-117">S-8</ix:nonNumeric> <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-118">EX-FILING FEES</ix:nonNumeric> <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-119">0000020212</ix:nonNumeric> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-120">Churchill Downs Inc</ix:nonNumeric> <ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="offrl_1" format="ixt:booleanfalse" id="ixv-121">Fees to be Paid</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/> </ix:references> <ix:resources> <xbrli:context id="rc"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000020212</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-22</xbrli:startDate> <xbrli:endDate>2025-04-22</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="offrl_1"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000020212</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-22</xbrli:startDate> <xbrli:endDate>2025-04-22</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> </ix:resources> </ix:header> </div> <div>
<table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
<tr>
<td colspan="4" style="padding-bottom: .5em"> <p> <b>Calculation of Filing Fee Tables</b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-146">S-8</ix:nonNumeric> </b> </p> </td> </tr>
<tr>
<td style="padding-bottom: .25em"> <p> <b> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-147">Churchill Downs Inc</ix:nonNumeric> </b> </p> </td> </tr> </table> </div> <div style="padding-bottom: 20px;">
<table style="float: center; width: 100%; text-align: left; ">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
<th style="vertical-align: bottom; text-align: center; width: 90%; word-wrap: break-word"> <p style="margin: 0pt; text-align: center;"> <b>Table 1: Newly Registered Securities</b> </p> </th> </tr> </table>
<table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 90%; text-align: center; border: 1px solid black; margin-left: auto; margin-right: auto;">
<tr style="background-color:#9ADAF6">
<th style="width: 2%;">
 </th>
<th style="width: 10%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Type</b> </p> </th>
<th style="width: 10%;"> <p style="margin: 0pt; text-align: center;"> <b>Security Class Title </b> </p> </th>
<th style="width: 10%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Calculation Rule</b> </p> </th>
<th style="width: 10%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount Registered</b> </p> </th>
<th style="width: 15%;"> <p style="margin: 0pt; text-align: center;"> <b>Proposed Maximum Offering Price Per Unit</b> </p> </th>
<th style="width: 15%;"> <p style="margin: 0pt; text-align: center;"> <b>Maximum Aggregate Offering Price</b> </p> </th>
<th style="width: 3%;"> <p style="margin: 0pt; text-align: center;"> <b>Fee Rate</b> </p> </th>
<th style="width: 15%;"> <p style="margin: 0pt; text-align: center;"> <b>Amount of Registration Fee</b> </p> </th> </tr>
<tr style="background-color:#E7E7E2">
<td style="text-align: center;"> 1 </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="offrl_1" id="ixv-148">Equity</ix:nonNumeric> </td>
<td style="text-align: left;"> <ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="offrl_1" id="ixv-149">Common Stock, no par value</ix:nonNumeric> </td>
<td style="text-align: center;"> <ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="offrl_1" format="ixt:booleantrue" id="ixv-150">Other</ix:nonNumeric> </td>
<td style="text-align: right;"> <ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="Shares" decimals="0" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-151">3,300,000</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-152">100.15</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-153">330,495,000.00</ix:nonFraction> </td>
<td style="text-align: right;"> <ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-154">0.0001531</ix:nonFraction> </td>
<td style="text-align: right;"> <span>$</span> <ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="offrl_1" id="ixv-155">50,598.78</ix:nonFraction> </td> </tr>
<tr>
<td colspan="5" style="vertical-align: top"> <p style="margin: 0pt; text-align: right">Total Offering Amounts:</p> </td>
<td>
 </td>
<td style="vertical-align: top; width: 16%;"> <p id="MaxAggtOfferingPrice" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-156">330,495,000.00</ix:nonFraction> </p> </td>
<td>
 </td>
<td style="vertical-align: top; border-bottom: 1px black; width: 16%;"> <p id="TotalFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-157">50,598.78</ix:nonFraction> </p> </td> </tr>
<tr>
<td colspan="5" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Total Fee Offsets: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="TotalOffsetAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-158">0.00</ix:nonFraction> </p> </td> </tr>
<tr>
<td colspan="5" style="vertical-align: top"> <p style="margin: 0pt; text-align: right"> Net Fee Due: </p> </td>
<td>
 </td>
<td>
 </td>
<td>
 </td>
<td style="vertical-align: top"> <p id="NetFeeAmt" style="margin: 0pt; text-align: right"> <span>$</span> <ix:nonFraction name="ffd:NetFeeAmt" contextRef="rc" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-159">50,598.78</ix:nonFraction> </p> </td> </tr> </table> </div> <div>
<table style="width: 100%; text-indent: 0px;"> <tbody>
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td> <p style="margin:0pt;text-align:left; margin-bottom: 5px;"> <b>Offering Note</b> </p> </td>
<td/> </tr> </tbody> </table> </div> <div style="padding-bottom: 20px;">
<table style="width: 100%; text-indent: 0px;">
<tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; vertical-align: top;">
<td style="width:10pt;"> <p style="margin:0pt;text-align:left;"> <sup style="vertical-align:top;line-height:120%;font-size:10px">1</sup> </p> </td>
<td colspan="7" style="white-space: pre-line;"> <ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="offrl_1" id="ixv-160">(a) Churchill Downs Incorporated, a Kentucky corporation (the "Registrant"), is registering 3,300,000 shares of common stock, no par value (the "Shares"), that may be issued under the Churchill Downs Incorporated 2025 Omnibus Stock and Incentive Plan (the "Plan"). Pursuant to Rule 416 of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers such additional and indeterminate number of securities as may become issuable pursuant to the provisions of the plans relating to adjustments for changes resulting from a stock dividend, stock split or similar change. (b) The offering price per unit and in the aggregate are estimated in accordance with Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee. The price of $100.15 per share represents the average high and low sales prices of the Common Stock as quoted on the Nasdaq Stock Market LLC on April 21, 2025. (c) The number of shares listed in row 1 represents Shares that may be issued under the Plan.</ix:nonNumeric> </td> </tr>
<tr>
<td style="width:10pt;"/>
<td colspan="7"> <hr style="width:100%;text-align:left;margin-left:0"/> </td> </tr> </table> </div> </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g902037kjab.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g902037kjab.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MY4-'%+FB_B7W=OD>*?"#]LB_^*'[0OBGX&2^ [?1H/#4_C*!?$::Z]Y+=?\
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M^8/,\#3Q;IJESN245T4;(\WB'*89'FE;+J=5UXT5%J;23?,K[+L>X5ZAX84
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M_+09ZLP:C1I0DUSIGB<)4Y2QV,KTTXT+.RZ)MZ+MIY"?LEC_ (S^^*';%_\
M&$>G_,=2C$:8*EY<OYBR33B7%=/XA^X(X%>/M\C]!7;;E,#Q3XDTKP?X=UWQ
M3KEPMIH_AS2-0UO4[ABH$5CIEK)=W!&X@%S'$55<\LRJ.33C%RE&$=Y.QG5J
MQP]*I5GI"E%R;\ELOF]#^;?5O!_C3]H+PU^T3^U#>27$)\->)]%U$V48+!K7
M5[UENK6"4_-&N@:!_8K#8>,DG&*^A4Z>']EA_P":-C\JJ4,1F,<PS57M1JQL
M[7TOT]-#]R_V1?C"/C1\#/"'B:[F63Q'I5O_ ,(KXM3=EU\0:%'%:RW3@DD"
M^L_LE\"<#_3& ^[7BXNBZ%:4>DM4S]"R3&K&Y?1J7O4II1FO-*R?S2_,_*O]
MOGPQJ7C;]L#2?!NC+;MJ_BCPOX#T+2TNI!#;/?ZC<ZM;VL<\I!$4;2LB%B"%
MW9/ KT\ODJ>%FY?"G8^,XGI3K9U3HT_CJ4X1CWOTU^1]'_L._M1:M8:JO[,W
MQJDN]+\7^&[R;0/!NHZZ6BO9I=.=H7\$:Q),<G4[4)BPF9C]HA"P@LR1>;S8
MS#1:5>CK%_$CV.'\XG&?]EX^7+7I-QA*6E[:*&O7M_P=/,?V&QC]M'XWC&,6
MOQ)Z\8QX^LQTK7&:8*@NJL<7#RMGN/Z?&[?/].A]!?\ !1_CPU\*?;Q'XB_3
M2K2OROC=_P"SX-=IR_)']*>%2MF69?\ 7F'X29[9^PO_ ,F[>&O;7/%GZ:Y=
MUZ_"7NY+0\I3_-'SW'ZMQ-B_*-+_ -)/L*OICXL* "@!I[?[P_E1V&M/N9_.
MU^SG\%?#WQR_:L\8^'?%KN_AGP[KWC?Q;J^E)O0^((]/\4M:P:-+,C*UO9S7
M%[&T[*0[11/&I4R;E]^O7EA\+3Y-)/9V_K8_+<KR^GC\YKTZVE*G4J2<>]F]
M+_U8[SQGH_BW_@GQ^TK9^*_#<-_J/PE\823M;V6\F+6/"<MRDNK^%+F1OD_M
M_0I)4GLI7PSHMNY^6:85G"4<=A^66E2FM_/H==:G7X9S15J*;P5=ZWZP>T?-
MKY6M?L?J%\<_VA_#W@O]FS6/C)X1U2WU*'Q#H%O;_#ZZAD&+S7/$L9M-(;;G
M*2V3O/<SPGYH_P"S9D8!E./-H8>4L0J,O=Y7[WHCZ[,,RHT,JGC*<TU4@U3]
M9*RZ[QZVZGY)?LCW'[3GPUMM=^)'PC^!J_$>W\<0+IA\4ZTER4,.E:C<R:C'
MIS6^L6;R"?526GD=7W26:!3\IKU,4L-*U*=;E]GLOZ['Q>2?VOAO:XO"X'VZ
MKZ-O35.[:?K^!A:/XQ^)W[//[5.A?%GXD^ 9OAG)XT\07^K^(/#,2%-+G\+>
M)[P6'B9M-#7=P6MX+R4WRI)*S1S6Z<!2M5*-.OAI4Z<N=TUH_-+]#.G6QF69
MO#%XJ@\(J\KSALG&;::7DM=3[#_X*I7,4_@GX+7=K+'/!-KWBFYMIXV#Q30R
M:%I\L$L;*<,CQE6!'4-7)EBY9U4UK%?E<]GC&498? -.\92;3\FHV_ ]!^%_
M_!/;]G/7O!'@/Q;K&G>+[^_UWPEX;UW4K1_%=U!I\U]JFD6E]=A8;2WBECMS
M//)MC68;5(&>*BICL1"<X1:BHMI:?\$ZL#PQE57#8>K4A4DYPC)ISTYGOH??
M/@3X>>"_ACX>M/"O@/PYIGA?0+1WEBT[2X/+1[B7'G75W,Y:6]O) J[IYWDD
M;: 6P !P3G*H[RDY,^FP^&H8.FJ.'IJE3C]F*_%]6_,_%[]F37M#\.?MY?%'
M4/$&LZ5H6G#4_B[";_6=1M-,LA/+KR^5#]JO98XA*^UMJ;LG:< XKU\1&3P=
M)1BW;EV78^"RBK3H<1XN=2I&G%.JDY-):;:O\#]D!\7OA2HY^)_P\ 7G_D=/
M#@P!_P!Q&O)5*K_S[>GDS[KZ[@];8FGI_?3/@?\ X*4_&BVT'X4^'_AMH&IP
MRWOQ1FCU/4);&X297\#:.\%VTD<D)82VNI:FUC$C(666*"<#(S7?EM&]5U)J
MRI_@_P#ACYOBO'>RP=/"TIVGB6OAZQO9+3N_R1\[?"AOVP/AQ\&;[X1Z%^RS
M8:[X0\4VNN3:MJ&LPW0U36HO%EJ8I[BZ6'Q!#&DB6#V\42^2IC6VC# ,IK>L
M\-4K*JZ_+*+M9/:QYN"6=X7 /"4\K4Z-:]Y/>TUO;K;>/9E3_@GWXZUSX-_'
M3Q+\"/'=M>>'I/&*"R;1M4*QS:7X[T*U-W90N S)YM_HLD\*LC%96BM<$Y7+
MQU-5,/"K!\RA]KR]?Q(X9Q%7 YA6R_$Q='VKLHRT:DM4K=&]CIOVF0/^'BWP
M@_Z_OA![=-;OL5&%TP%5;;FV<*W$F"T_Y]K[E_P3Z _;J_92N/']DWQJ^&%G
M+;_$WPG%#=ZS8:9N@N_%FDZ5MFM[VR:':W_"4:4L*R6[J0\\,7D@^9'#6&!Q
M7LVJ-76FW9>7S/2XBR:6)A]>PD>7$T%>5M')+K9?:5MSY(_X)J7]YJG[1OC#
M4]1N)KO4=1^'_B"^U"ZN,FXN;VZ\1:+-=W%P2 ?M#SM(SY .XMD9KJS))4:?
M+\*>AX?"3G+,JTIW<I0:ES;W7?\ S/K;_@I!_P BU\*NV/$7B+VZ:5:5^4<;
M_P #!]+5)?D?T[X4_P#(RS+RH0_]*D>V_L+\?L[>&O\ L-^*_P#T^75>OPG_
M ,B6A_BJ?FCY[Q _Y*;&=+1I_P#I)]@U],?%!0 4 -(/; QZ\<CITH_)= V\
MCY-^#W[(?@3X+?$OQ+\4/#OB#Q5J6M>*;?6K:]LM8GTV33($US5XM8N6M4M;
M"&562XA5$WRN-A(.3S735Q52K3C2:24;6^1XV R7#X#%5,72J2E.JVY1>VNK
M/5/C7\%/!?QW\#WG@3QI!.+&:XMK[3]4L'BBUC0]3M&S#J.E7$T4B0SF)I(7
M5T=)(IY$=2&&,J%6>'GS0=K+8Z\=@*&88?ZO7C[L7>+MJK;6OL?*US_P3R\!
M7G@;3/AM<?%'XJ2^"]%U^_\ $^EZ(]]X?,%CK.HVJVEW<0L=$W"$H)'6 GRT
MEN9Y% :=R>E8Z<9.?LX\S5F^IY$N&</+#0PDL55E0A+F47;23^?7J?:/PX\!
M:'\+_ _A?P!X;25=#\*:1;:18-<,KW4Z09,MW=O&B*]Y<7#RSRLJJ#),Q  X
MKDG-U)N;WD>]A</3PF'I8:DK4Z*LCR+]HC]E_P !?M(V7ANU\8WNM:3<>%KJ
M^GTW4O#\ME!?-;ZE!'#>Z?<M>VEPDEF[P6\NT*"KP@@X)SMA\3/#.7)9\VC3
M.+,\IP^:1I*LW&5%WC);KRW1Q_Q(_8V\%_%/X;_#/X:>*?&/C>73OA;;W%IH
MNLP7.E#6M0MYK*+3HDU>6;39(9C!9001(T<49(B!;)SFJ>+G1G.4(J\UJNUC
M#%Y%A\;AL+AJM:?)A/ADM_3[M#ZE\*^'[;PGX9\/>%[*:>>R\-Z)I6A6<]R4
M-S-:Z38P6%O+<F-%0SM% I8HJC<3@ <5S2GS-R:MS'K4*4:%*G1A\-**BN]D
M;YSCCM@_E2V^1KM\C\Z?%G_!-?X/>,?$_B3Q5J?B[X@PWWB;7=4U^]M[:[T)
M;2"ZU6\EO9XK9)=&=Q DDS*@=V8 #))YKOAF%:G&,%%-1V/F*_"N!K5JE:56
MI&567,^7N]3FW_X)8? ]T9/^$Q^(P#*5.+GPYP",?] 'TI_VE5LU[.*N9+A+
M IIJO537]=T>L>+?V$OAIXW\8^#_ !?XE\4^-K\^"=&\%>'=(T![K25T1M%\
M#PVT=CI]Q#_9AE,5Y+!)-=[)4\Q[N7;M7:%RCC*E.,HP22E>[.VMP_A*^(HU
MJM64O8*$8I[>ZDC[?"84#A0!C X QP !V '%<:6M[69[ZTLDK*.R7EHCX]^)
M_P"QA\/OB;\6;'XS3>)/%_A3QE82>'[I9?#5QIEO:S:CX9E1].U*9+O3IG-W
MY44$$A#@/' @(ZD]E/%U*=%T;*4.S/#Q61X7%8V&.<ITZT'%^[U<-F;'CO\
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MZCXDT:[NYUCC 2,23RR/M4 #=@#%=&9)0P\(K:+5CR^$YRGF=>=36I*G=O\
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M8USQ9[=-<NJ]7A+_ )$N'Z>]4_-'@>(&G$^,\HT__23["KZ8^*"@ H * "@
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M;7XA]O\ BAO%G_IBOZ=+2K3Z6:_-&>,_W3$KI[*?_I)^''["47[-4FE_$?\
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MK;3T5CZ _P""C_\ R+7PI_[&+Q%^&-*M*_*>-_X&#_Z^2_)'](^%.F8YDO\
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M<?3NFV]XIZ\M]=-;OJNW7FO^"GIQ\8O@QCC_ (I27V_YFV'%/+FE1K]%_P
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*8/TH_0-O*Q__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Apr. 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000020212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Churchill Downs Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Apr. 22, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">100.15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 330,495,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 50,598.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">(a) Churchill Downs Incorporated, a Kentucky corporation (the "Registrant"), is registering 3,300,000 shares of common stock, no par value (the "Shares"), that may be issued under the Churchill Downs Incorporated 2025 Omnibus Stock and Incentive Plan (the "Plan"). Pursuant to Rule 416 of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers such additional and indeterminate number of securities as may become issuable pursuant to the provisions of the plans relating to adjustments for changes resulting from a stock dividend, stock split or similar change. (b) The offering price per unit and in the aggregate are estimated in accordance with Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee. The price of $100.15 per share represents the average high and low sales prices of the Common Stock as quoted on the Nasdaq Stock Market LLC on April 21, 2025. (c) The number of shares listed in row 1 represents Shares that may be issued under the Plan.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Apr. 22, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 330,495,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">50,598.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 50,598.78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *"4EUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( *"4EUJ)E7H@[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M1*<ZK:T;]'#-<#0(+ZQ;:\SASV2'V)4)(HD]QA"GD<09F]5(1L%H-NU-IA=
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MX^+J;14D<!'"N+HHD2VRYS5G#%@NQ8&964V=7<K1;;-;'*%PJU".Q/_@1&/
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M -_O!+I>WIAIN?K86?X'4$L#!!0    ( *"4EUJ>9[LM*0(  %P%   8
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M&,VT7^%ZV06*U[9_MESI;K330C]_($R"WL\Y5Z? M&3WH*9_ 5!+ P04
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MV)Z#!^=1M#FGHNTO(;/?4$L#!!0    ( *"4EUJ7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ H)276E)Q;[5= 0
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M8R_)51J'^:94II<\1U.!EGDK*X3 \VY@]@R11'NFDTT:_R&JLFQR?*C\U>/
M/\#P5J:E&I&%DTE3(<<"QFX;$RR'[\YDX:1%+$Q:^ +.%@HLH>!\H= 2"@\4
M(IXZI,UFS5;]Y<!ZGM_BUK[$=6@OR?7K -972#Y02P,$%     @ H)276J;\
M2ELC 0  WP0  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS93/3L,P#,9?I>IU
M:C*&Q &MNP!7V($7"(V[1LT_Q=[HWAZWW2:!1L4T)+@T:FQ_/\>?DN7K/@)F
MG;,>R[PABO=28M6 4RA"!,^1.B2GB'_31D95M6H#<C&?W\DJ> )/!?4:^6KY
M"+7:6LJ>.MY&$WR9)["89P]C8L\J<Q6C-94BCLN=UU\HQ8$@N'+(P<9$G'%"
M+L\2^LCW@$/=RPY2,AJRM4KTK!QGR<Y*I+T%%-,29WH,=6TJT*':.BX1&!,H
MC0T .2M&T=DTF7C",'YOKN8/,E- SERG$)$=2W Y[FA)7UU$%H)$9OJ()R)+
M7WT^Z-W6H'_(YO&^A]0.?J <ENMG_-GCD_Z%?2S^21^W?]C'6PCM;U^Y?A5.
M&7_DR^%=6WT 4$L! A0#%     @ H)276D;'34B5    S0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "@E)=:B95Z
M(.\    K @  $0              @ '#    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " "@E)=:F5R<(Q &  "<)P  $P              @ 'A 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *"4EUH9>-FE0@(  # &
M   8              " @2((  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " "@E)=:CP U4.0$  #X#   &               @(&:"@
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ H)276IYGNRTI
M @  7 4  !@              ("!M \  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( *"4EUHK("U^%@,  !81   -              "
M 1,2  !X;"]S='EL97,N>&UL4$L! A0#%     @ H)276I>*NQS     $P(
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9>&UL4$L%!@     +  L R@(   T:      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>19</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="d902037dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d902037dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d902037dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d902037dexfilingfees.htm">d902037dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="18">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d902037dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d902037dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 19,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 4,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 18,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d902037dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "offrl_1",
      "name": "ffd:FeesOthrRuleFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d902037dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d902037dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d902037dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-25-091650-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-091650-xbrl.zip
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MHKZ-L86*%Y$![T$;A!B$$16WME:[?(-, N;S" ;J<Z>YK&F<1H$T^?)+CN_
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MPJ0$S$:T\.@/H (Z&OPGU085TUAYB1_2>,*01J?"$HV5C" <+'8$B@"^8X0
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M9JLO")K9=PQVM&K7=J>^BU_G&OP/4$L! A0#%     @ H)276B7KCMM="0
M("8  !@              ( !     &0Y,#(P,S=D97AF:6QI;F=F965S+FAT
7;5!+!08      0 ! $8   "3"0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d902037dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000020212</identifier>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="offrl_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000020212</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-116">S-8</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-117">S-8</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-118">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-119">0000020212</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-120">Churchill Downs Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="offrl_1" id="ixv-121">false</ffd:PrevslyPdFlg>
    <ffd:FormTp contextRef="rc" id="ixv-146">S-8</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-147">Churchill Downs Inc</dei:EntityRegistrantName>
    <ffd:OfferingSctyTp contextRef="offrl_1" id="ixv-148">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="offrl_1" id="ixv-149">Common Stock, no par value</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="offrl_1" id="ixv-150">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="offrl_1"
      decimals="0"
      id="ixv-151"
      unitRef="Shares">3300000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-152"
      unitRef="USD">100.15</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-153"
      unitRef="USD">330495000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-154"
      unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="offrl_1"
      decimals="INF"
      id="ixv-155"
      unitRef="USD">50598.78</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="rc" decimals="INF" id="ixv-156" unitRef="USD">330495000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="rc" decimals="INF" id="ixv-157" unitRef="USD">50598.78</ffd:TtlFeeAmt>
    <ffd:TtlOffsetAmt contextRef="rc" decimals="INF" id="ixv-158" unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="rc" decimals="INF" id="ixv-159" unitRef="USD">50598.78</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="offrl_1" id="ixv-160">(a) Churchill Downs Incorporated, a Kentucky corporation (the "Registrant"), is registering 3,300,000 shares of common stock, no par value (the "Shares"), that may be issued under the Churchill Downs Incorporated 2025 Omnibus Stock and Incentive Plan (the "Plan"). Pursuant to Rule 416 of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers such additional and indeterminate number of securities as may become issuable pursuant to the provisions of the plans relating to adjustments for changes resulting from a stock dividend, stock split or similar change. (b) The offering price per unit and in the aggregate are estimated in accordance with Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee. The price of $100.15 per share represents the average high and low sales prices of the Common Stock as quoted on the Nasdaq Stock Market LLC on April 21, 2025. (c) The number of shares listed in row 1 represents Shares that may be issued under the Plan.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
